このアイテムのアクセス数: 747
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
jamanetworkopen.2023.5174.pdf | 884.58 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Inoue, Kosuke | en |
dc.contributor.author | Tsugawa, Yusuke | en |
dc.contributor.author | Mayeda, Elizabeth Rose | en |
dc.contributor.author | Ritz, Beate | en |
dc.contributor.alternative | 井上, 浩輔 | ja |
dc.contributor.alternative | 津川, 友介 | ja |
dc.date.accessioned | 2023-03-31T06:28:29Z | - |
dc.date.available | 2023-03-31T06:28:29Z | - |
dc.date.issued | 2023-03 | - |
dc.identifier.uri | http://hdl.handle.net/2433/281527 | - |
dc.description | 1週間の歩行パターンと死亡リスクの関連を明らかに --週2回しっかり歩くことで健康は維持できるか?--. 京都大学プレスリリース. 2023-03-30. | ja |
dc.description.abstract | [Importance] Previous studies have shown that individuals who regularly walk, particularly 8000 daily steps or more, experience lower mortality. However, little is known about the health benefits of walking intensively only a few days a week. [Objective] To evaluate the dose-response association between the number of days an individual takes 8000 steps or more and mortality among US adults. [Design, Setting, and Participants] This cohort study evaluated a representative sample of participants aged 20 years or older in the National Health and Nutrition Examination Surveys 2005-2006 who wore an accelerometer for 1 week and their mortality data through December 31, 2019. Data were analyzed from April 1, 2022, to January 31, 2023. [Exposures] Participants were grouped by the number of days per week they took 8000 steps or more (0 days, 1-2 days, and 3-7 days). [Main Outcomes and Measures] Multivariable ordinary least squares regression models were used to estimate adjusted risk differences (aRDs) for all-cause and cardiovascular mortality during the 10-year follow-up, adjusting for potential confounders (eg, age, sex, race and ethnicity, insurance status, marital status, smoking, comorbidities, and average daily step counts). [Results] Among 3101 participants (mean [SD] age, 50.5 [18.4] years; 1583 [51.0%] women and 1518 [49.0%] men; 666 [21.5%] Black, 734 [23.7%] Hispanic, 1579 [50.9%] White, and 122 [3.9%] other race and ethnicity), 632 (20.4%) did not take 8000 steps or more any day of the week, 532 (17.2%) took 8000 steps or more 1 to 2 days per week, and 1937 (62.5%) took 8000 steps or more 3 to 7 days per week. Over the 10-year follow-up, all-cause and cardiovascular deaths occurred in 439 (14.2%) and 148 (5.3%) participants, respectively. Compared with participants who walked 8000 steps or more 0 days per week, all-cause mortality risk was lower among those who took 8000 steps or more 1 to 2 days per week (aRD, −14.9%; 95% CI −18.8% to −10.9%) and 3 to 7 days per week (aRD, −16.5%; 95% CI, −20.4% to −12.5%). The dose-response association for both all-cause and cardiovascular mortality risk was curvilinear; the protective association plateaued at 3 days per week. Different thresholds for the number of daily steps between 6000 and 10 000 yielded similar results. [Conclusions and Relevance] In this cohort study of US adults, the number of days per week taking 8000 steps or more was associated with a lower risk of all-cause and cardiovascular mortality in a curvilinear fashion. These findings suggest that individuals may receive substantial health benefits by walking just a couple days a week. | en |
dc.language.iso | eng | - |
dc.publisher | American Medical Association (AMA) | en |
dc.rights | © 2023 Inoue K et al. JAMA Network Open. | en |
dc.rights | This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License. | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.title | Association of Daily Step Patterns With Mortality in US Adults | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.jtitle | JAMA Network Open | en |
dc.identifier.volume | 6 | - |
dc.identifier.issue | 3 | - |
dc.relation.doi | 10.1001/jamanetworkopen.2023.5174 | - |
dc.textversion | publisher | - |
dc.identifier.artnum | e235174 | - |
dc.address | Department of Social Epidemiology, Graduate School of Medicine, Kyoto University | en |
dc.address | Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles; Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles | en |
dc.address | Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles | en |
dc.address | Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles; Department of Environmental Health Sciences, Fielding School of Public Health, University of California, Los Angeles; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles | en |
dc.identifier.pmid | 36976556 | - |
dc.relation.url | https://www.kyoto-u.ac.jp/ja/research-news/2023-03-30 | - |
dcterms.accessRights | open access | - |
datacite.awardNumber | 21K20900 | - |
datacite.awardNumber | 22K17392 | - |
datacite.awardNumber.uri | https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K20900/ | - |
datacite.awardNumber.uri | https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K17392/ | - |
dc.identifier.eissn | 2574-3805 | - |
jpcoar.funderName | 日本学術振興会 | ja |
jpcoar.funderName | 日本学術振興会 | ja |
jpcoar.awardTitle | 厳格な降圧管理が心血管予防に効果的である集団の同定と、一般集団への介入効果の検討 | ja |
jpcoar.awardTitle | 糖尿病を介して心血管疾患を引き起こす社会決定要因の同定と、そのメカニズムの解明 | ja |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス